UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Physiology and effects of nucleosides in mice lacking all four adenosine receptors

PLoS biology, 2019-03, Vol.17 (3), p.e3000161-e3000161

2019

Volltextzugriff (PDF)

A2B Adenosine Receptor and Cancer

International journal of molecular sciences, 2019-10, Vol.20 (20), p.5139

2019

Volltextzugriff (PDF)

Treatment of chronic neuropathic pain: purine receptor modulation

Pain (Amsterdam), 2020-07, Vol.161 (7), p.1425-1441

2020

Volltextzugriff (PDF)

Update of P2Y receptor pharmacology: IUPHAR Review 27

British journal of pharmacology, 2020-06, Vol.177 (11), p.2413-2433

2020

Volltextzugriff (PDF)

Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines

British journal of pharmacology, 2022-07, Vol.179 (14), p.3496-3511

2022

Volltextzugriff (PDF)

International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update

Pharmacological reviews, 2022-04, Vol.74 (2), p.340-372

2022

Volltextzugriff (PDF)

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update

Pharmacological reviews, 2011-03, Vol.63 (1), p.1-34

2011

Volltextzugriff (PDF)

Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development

Frontiers in cellular neuroscience, 2019-03, Vol.13, p.124-124

2019

Volltextzugriff (PDF)

Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling

Structure (London), 2018-02, Vol.26 (2), p.259-269.e5

2018

Volltextzugriff (PDF)

Anionic phospholipids control mechanisms of GPCR-G protein recognition

Nature communications, 2023-02, Vol.14 (1), p.794-794, Article 794

2023

Volltextzugriff (PDF)

Purinergic Signaling in Liver Pathophysiology

Frontiers in endocrinology (Lausanne), 2021-08, Vol.12, p.718429-718429

2021

Volltextzugriff (PDF)

Two disparate ligand-binding sites in the human P2Y1 receptor

Nature (London), 2015-04, Vol.520 (7547), p.317-321

2015

Volltextzugriff (PDF)

Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2A Adenosine Receptor

Cell, 2018-01, Vol.172 (1-2), p.68-80.e12

2018

Volltextzugriff (PDF)

Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets

Biochemical pharmacology, 2021-05, Vol.187, p.114311-114311, Article 114311

2021

Volltextzugriff (PDF)

Renal intercalated cells sense and mediate inflammation via the P2Y14 receptor

PloS one, 2015-03, Vol.10 (3), p.e0121419-e0121419

2015

Volltextzugriff (PDF)

On the G protein-coupling selectivity of the native A2B adenosine receptor

Biochemical pharmacology, 2018-05, Vol.151 (C), p.201-213

2018

Volltextzugriff (PDF)

Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates

Journal of medicinal chemistry, 2013-05, Vol.56 (10), p.3749

Jacobson, Kenneth A

2013

Volltextzugriff (PDF)

Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist Binding

Molecules (Basel, Switzerland), 2017-03, Vol.22 (3), p.449

2017

Volltextzugriff (PDF)

Agonist-bound structure of the human P2Y12 receptor

Nature (London), 2014-05, Vol.509 (7498), p.119-122

2014

Volltextzugriff (PDF)

Purinergic Signaling in Mast Cell Degranulation and Asthma

Frontiers in pharmacology, 2017-12, Vol.8, p.947-947

2017

Volltextzugriff (PDF)

Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms

Pain (Amsterdam), 2018-06, Vol.159 (6), p.1025-1034

2018

Volltextzugriff (PDF)

Editorial: Purinergic pharmacology, Volume II

Frontiers in pharmacology, 2023-05, Vol.14, p.1200187-1200187

2023

Volltextzugriff (PDF)

Optical Control of Adenosine A3 Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis?

Frontiers in immunology, 2022-04, Vol.13, p.904762-904762

2022

Volltextzugriff (PDF)

A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways

Pain (Amsterdam), 2014-12, Vol.155 (12), p.2560-2567

2014

Volltextzugriff (PDF)

Enhancement of glucose uptake in mouse skeletal muscle cells and adipocytes by P2Y6 receptor agonists

PloS one, 2014-12, Vol.9 (12), p.e116203

2014

Volltextzugriff (PDF)

1 – 25 von 2.148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.928)
Mit Volltextzugriff
(1.919)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.139)
Deutsch
(4)
Japanisch
(3)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(721)
Life Sciences & Biomedicine
(630)
Humans
(611)
Animals
(521)
Biological And Medical Sciences
(364)
Medical Sciences
(281)
Male
(239)
Pharmacology & Pharmacy
(233)
Structure-Activity Relationship
(220)
Pharmacology. Drug Treatments
(213)
Female
(191)
Rats
(185)
Ligands
(164)
Adenosine - Analogs & Derivatives
(158)
Mice
(143)
Neuropharmacology
(138)
Chemistry, Medicinal
(123)
Neurotransmitters. Neurotransmission. Receptors
(120)
Adenosine - Pharmacology
(116)
Models, Molecular
(115)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Physiology and effects of nucleosides in mice lacking all four adenosine receptors

A2B Adenosine Receptor and Cancer

Treatment of chronic neuropathic pain: purine receptor modulation

Update of P2Y receptor pharmacology: IUPHAR Review 27

Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines

International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update

Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development

Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling

Anionic phospholipids control mechanisms of GPCR-G protein recognition

Purinergic Signaling in Liver Pathophysiology

Two disparate ligand-binding sites in the human P2Y1 receptor

Allosteric Coupling of Drug Binding and Intracellular Signaling in the A2A Adenosine Receptor

Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets

Renal intercalated cells sense and mediate inflammation via the P2Y14 receptor

On the G protein-coupling selectivity of the native A2B adenosine receptor

Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates

Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist Binding

Agonist-bound structure of the human P2Y12 receptor

Purinergic Signaling in Mast Cell Degranulation and Asthma

Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms

Editorial: Purinergic pharmacology, Volume II

Optical Control of Adenosine A3 Receptor Signaling: Towards a Multimodal Phototherapy in Psoriasis?

A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways

Enhancement of glucose uptake in mouse skeletal muscle cells and adipocytes by P2Y6 receptor agonists

Suchergebnisse filtern